Business Ethics, Corporate Social Responsibility Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs
Business Ethics, Regulation & Legislation Drug Companies Pay Up in Illegal Marketing Cases, But Are Penalties Enough?
Business Ethics, Regulation & Legislation Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs
Corporate Social Responsibility, Economy & Society, Environmental Sustainability, Sustainable Investing Sustainability Reporting Group Issues First Standards for SEC Filings
Business Ethics, Governance & Compliance, Regulation & Legislation Pfizer’s Latest Twist on ‘Pay for Delay’
Business Ethics, Governance & Compliance, Regulation & Legislation Doctors Avoid Penalties in Suits Against Medical Firms
Corporate Social Responsibility, Sustainable Investing Investors Press Companies on U.S. Chamber Board Roles
Corporate Social Responsibility, Governance & Compliance, Regulation & Legislation, Sustainable Investing Opinion: U.S. Chamber of Commerce and A Failure in Governance
Business Ethics, Governance & Compliance, Regulation & Legislation Docs on Pharma Payroll Have Blemished Records
Business Ethics, Governance & Compliance, Regulation & Legislation Lawsuits Say Pharma Illegally Paid Doctors to Push Their Drugs
Business Ethics, Corporate Social Responsibility, Environmental Sustainability, Governance & Compliance, Sustainable Investing Verbatim: How Businesses View Sustainability & CSR Reporting